Emily Holthuis

PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands, Netherlands

Poster(s):

• (8) Brodalumab Assessment of Hazards: A Multinational Safety (BRAHMS) Study of a Biological Anti-Psoriatic Drug Across Six European Countries
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (198) Extracting Pregnancies from Heterogeneous Data Sources in Europe: A Novel Algorithm in The Conception Project
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (51) Incidence of Lyme Borreliosis in The Dutch General Practice Population: A Large-Scale Population-Based Cohort Study Across the Netherlands Between 2015 and 2019
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST